BLU 14.74 (+0%)
CA07987C2040BiotechnologyBiotechnology

BELLUS Health (BLU) Stock Highlights

14.74 | +0%
2023-08-03 17:45:00
BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with a high unmet medical need, including BLU-5937, P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The company operates in one business segment namely, the development of drug candidates for health solutions.

Statistics

Range Today
14.74 14.74
Volume Today 0
Range 1 Year
6.38 14.76
Volume 1 Year 468.01M
Range 3 Year
2.01 14.76
Volume 3 Year 1.31B
Range 10 Year
0.6137 14.76
Volume 10 Year 1.48B

Highlights

Market Capitalization 1.87B (small)
Floating Shares 92.13M
Current Price 14.74
Price To Earnings -20.19
Price To Revenue 103.82K
Price To Book 5.06
Earnings Per Share -0.73
Payout Ratio 0%

Performance

Latest 0%
1 Month +0.96%
3 Months +116.13%
6 Months +82.88%
1 Year +34.61%
3 Years +283.85%
5 Years +849.56%
10 Years +1675.26%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.